Skip to main content
Premium Trial:

Request an Annual Quote

Seer Prices $110.5M Follow-on Stock Offering

NEW YORK – Proteomics firm Seer said on Wednesday that it has priced an underwritten public offering of 3.75 million shares of Class A common stock at $67 per share.

The offering will consist of 1.65 million shares sold by Seer and 2.1 million shares sold by stockholders of Seer. Gross proceeds to Seer will be around $110.5 million.

Additionally, the selling stockholders will grant the underwriters a 30-day option to purchase up to 562,500 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions.

The company will use the proceeds to commercialize its Proteograph Product Suite and for development work on the Proteograph system and other R&D and corporate purposes. The ProteoGraph system uses nanoparticle-based enrichment of proteins in samples like human plasma to enable deeper coverage in proteomic discovery experiments.

JP Morgan, Morgan Stanley, BofA Securities and Cowen are acting as lead book-running managers for the offering.

The offering is expected to close on or about Feb. 1, 2021.

Seer went public less than two months ago, raising around $175 million in its market debut. It also raised $135 million in a concurrent private financing.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.